stocks logo

SNN

Smith & Nephew PLC
$
30.930
+0.65(2.147%)1D
  • Overview
  • Forecast
  • Valuation
  • Earnings
Line
Line
|
Candle
Candle
1D
5D
1M
3M
6M
YTD
1Y
5Y
High
30.9583
Open
30.410
VWAP
30.78
Vol
949.15K
Mkt Cap
13.55B
Low
30.400
Amount
29.21M
EV/EBITDA(TTM)
10.71
Total Shares
875.96M
EV
15.91B
EV/OCF(TTM)
16.12
P/S(TTM)
2.27
Smith & Nephew plc is a portfolio medical technology company. The Company is engaged in developing, manufacturing, marketing, and selling medical devices and services. It is focused on the repair, regeneration, and replacement of soft and hard tissue. The Company's segments include Orthopaedics, Sports Medicine & ENT and Advanced Wound Management. Its Orthopaedics segment includes a range of hip, knee and shoulder implants used to replace diseased, damaged or worn joints, robotics-assisted enabling technologies that empower surgeons, and trauma products used to stabilise severe fractures and correct bone deformities. Its Sports Medicine & Ear, Nose and Throat (ENT) businesses offer advanced products and instruments used to repair or remove soft tissue. Its Advanced Wound Management portfolio provides a comprehensive set of products to meet broad and complex clinical needs, and to help healthcare professionals reduce the human and economic consequences of wounds.
Show More

Market Estimates

Earnings Estimates
Revenue
YoY Chg
EPS
YoYChg
FY2029Q3
FY2029Q2
FY2029Q1
1.68B
+6.96%
--
--
1.51B
+6.79%
--
--
1.52B
+5.6%
--
--
Estimates Revision
The market is revising Upward the revenue expectations for Smith & Nephew plc (SNN) for FY2025, with the revenue forecasts being adjusted by 0.88% over the past three months. During the same period, the stock price has changed by 18.23%.
Revenue Estimates for FY2025
Revise Upward
up Image
+0.88%
In Past 3 Month
Stock Price
Go Up
up Image
+18.23%
In Past 3 Month
2 Analyst Rating
down Image
-7.44% Downside
Wall Street analysts forecast SNN stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for SNN is 28.63 USD with a low forecast of 28.00 USD and a high forecast of 29.26  USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
0 Buy
2 Hold
0 Sell
Hold
down Image
-7.44% Downside
Current: 30.930
sliders
Low
28.00
Averages
28.63
High
29.26
JPMorgan
NULL
to
Overweight
upgrade
2025-07-09
Reason
JPMorgan raised the firm's price target on Smith & Nephew to 1,357 GBp from 1,317 GBp and keeps an Overweight rating on the shares.
Citi
Buy
maintain
2025-06-05
Reason
Citi raised the firm's price target on Smith & Nephew to 1,450 GBp from 1,425 GBp and keeps a Buy rating on the shares.
HSBC
Buy
to
Hold
downgrade
2025-04-25
Reason
HSBC downgraded Smith & Nephew to Hold from Buy with a price target of 1,070 GBp, down from 1,160 GBp. The firm adjusted ratings in medical technology and life sciences are quantifying the risk/reward using stagflation, weak macro environment, and recovery scenario analyses. The market is debating whether the recent multiples correction is an opportunity to buy, or if it is the start of a potential recession, the analyst tells investors in a research note. HSBC's analysis of historical sector multiples reveals that the multiples compression might have an additional 20%-25% downside in a stagflation scenario. "We are far from the point where one can argue that these stocks are pricing in a recession," contends HSBC.
Canaccord Genuity
Caitlin Cronin
Hold
Maintains
$27
2025-03-17
Reason
UBS
Graham Doyle
Strong Buy
to
Hold
Downgrades
n/a
2025-03-12
Reason
Canaccord Genuity
Kyle Rose
Hold
Maintains
$27
2025-02-26
Reason

Valuation Metrics

The current forward P/E ratio for Smith & Nephew PLC (SNN.N) is 15.13, compared to its 5-year average forward P/E of 17.99. For a more detailed relative valuation and DCF analysis to assess Smith & Nephew PLC 's fair value, click here.

Forward PE

StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
Fair
5Y Average PE
17.99
Current PE
15.13
Overvalued PE
21.65
Undervalued PE
14.33

Forward EV/EBITDA

StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
Fair
5Y Average EV/EBITDA
11.29
Current EV/EBITDA
10.17
Overvalued EV/EBITDA
13.32
Undervalued EV/EBITDA
9.26

Forward PS

StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
Fair
5Y Average PS
2.47
Current PS
2.16
Overvalued PS
3.06
Undervalued PS
1.88

Financials

Annual
Quarterly

Trading Trends

Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
Hedge Fund
Hedge Funds areSelling! The selling amount has increased 225.52% over the last quarter.
Sold
0-3
Months
5.5M
Volume
10
3-6
Months
1.7M
Volume
3
6-9
Months
2.9M
Volume
15
0-12
Months
6.1M
Volume
15
Bought
0-3
2
225.5K
Volume
Months
3-6
2
3.8M
Volume
Months
6-9
8
7.2M
Volume
Months
0-12
7
22.1M
Volume
Months
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months

SNN News & Events

Events Timeline

2025-07-07 (ET)
2025-07-07
10:01:37
Smith & Nephew announces release of Q-FIX Knotless All-Suture Anchor
select
2025-06-24 (ET)
2025-06-24
10:05:03
Smith & Nephew announces launch of TRIGEN MAX Tibia Nailing System
select
2025-06-23 (ET)
2025-06-23
08:03:52
Smith & Nephew names Ajay Dhankhar chief corporate development, strategy officer
select
Sign Up For More Events

News

4.0
07-10NASDAQ.COM
Smith & Nephew Reaches Analyst Target Price
5.0
07-07Newsfilter
Smith+Nephew expands market-leading fixation strength of Q-FIX™ All-Suture Anchor portfolio with new knotless option
1.0
06-29Newsfilter
Global Sports Medicine leader Smith+Nephew to sponsor select players competing at Wimbledon, highlighting advanced solutions for joint repair
Sign Up For More News

FAQ

arrow icon

What is Smith & Nephew PLC (SNN) stock price today?

The current price of SNN is 30.93 USD — it has increased 2.15 % in the last trading day.

arrow icon

What is Smith & Nephew PLC (SNN)'s business?

arrow icon

What is the price predicton of SNN Stock?

arrow icon

What is Smith & Nephew PLC (SNN)'s revenue for the last quarter?

arrow icon

What is Smith & Nephew PLC (SNN)'s earnings per share (EPS) for the last quarter?

arrow icon

What changes have occurred in the market's expectations for Smith & Nephew PLC (SNN)'s fundamentals?

arrow icon

How many employees does Smith & Nephew PLC (SNN). have?

arrow icon

What is Smith & Nephew PLC (SNN) market cap?